These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20510039)

  • 1. [Establishment and identification of bone morrow specific transgenic mouse model with tumorigenesis by mutant Myc retrovirus infection.].
    Guo CB; Jin XQ; Zhang MM; Pu CL; Li YC; Kang Q
    Zhonghua Xue Ye Xue Za Zhi; 2010 Apr; 31(4):236-9. PubMed ID: 20510039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
    Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
    J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.
    Zörnig M; Grzeschiczek A; Kowalski MB; Hartmann KU; Möröy T
    Oncogene; 1995 Jun; 10(12):2397-401. PubMed ID: 7784089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations.
    Alexander WS; Bernard O; Cory S; Adams JM
    Oncogene; 1989 May; 4(5):575-81. PubMed ID: 2657573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
    Eischen CM; Alt JR; Wang P
    Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Vaux DL; Cory S; Adams JM
    Nature; 1988 Sep; 335(6189):440-2. PubMed ID: 3262202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
    Blasi E; Radzioch D; Merletti L; Varesio L
    Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
    Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
    Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
    Smith DP; Bath ML; Harris AW; Cory S
    Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Sochalska M; Schuler F; Weiss JG; Prchal-Murphy M; Sexl V; Villunger A
    Oncogene; 2017 Apr; 36(15):2066-2073. PubMed ID: 27694901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transgenic window on lymphoid malignancy.
    Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
    Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
    Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
    Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.
    Harris AW; Pinkert CA; Crawford M; Langdon WY; Brinster RL; Adams JM
    J Exp Med; 1988 Feb; 167(2):353-71. PubMed ID: 3258007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive bioluminescence imaging to monitor the immunological control of a plasmablastic lymphoma-like B cell neoplasia after hematopoietic cell transplantation.
    Chopra M; Kraus S; Schwinn S; Ritz M; Mattenheimer K; Mottok A; Rosenwald A; Einsele H; Beilhack A
    PLoS One; 2013; 8(12):e81320. PubMed ID: 24349055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF loss impairs Myc-induced lymphomagenesis.
    Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
    Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.